Nicolas Carlier

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · Science · 2020 · 3.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier et al. · BMJ · 2020 · 460 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · medRxiv · 2020 · 253 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial

Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier et al. · medRxiv · 2020 · 164 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients

Yann Nguyen, Adrien Flahault, Nathalie Chavarot et al. · Clinical Microbiology and Infection · 2022 · 109 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14